source
- First wave of ASH 2026 abstracts released, featuring data from J&J, Servier and AstraZenecaThe American Society of Hematology’s annual meeting is set for New Orleans, Louisiana, a little over a month away. The first batch of abstracts for the conference has been posted, showcasing early…
- AbbVie licenses Nxera's EP4 gut-targeting IBD program for up to $1.47 billionAbbVie announced a licensing agreement with Nxera Pharma to acquire rights to its EP4 receptor agonist program aimed at inflammatory bowel disease. The deal includes an upfront payment of $100 mil…